| FINVX | SVXLX | FINVX / SVXLX | |
| Total Expense Ratio | 0.01 | 1.26 | 1% |
| Annual Report Gross Expense Ratio | 0.01 | 2.83 | 0% |
| Fund Existence | 17 years | 11 years | - |
| Gain YTD | 8.013 | 23.784 | 34% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 17.8B | 307M | 5,798% |
| Annual Yield % from dividends | 4.06 | 1.39 | 291% |
| Returns for 1 year | 18.47 | 48.57 | 38% |
| Returns for 3 years | 75.62 | 99.78 | 76% |
| Returns for 5 years | 81.91 | N/A | - |
| Returns for 10 years | 155.29 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XLU | 45.07 | 0.35 | +0.78% |
| State Street®UtilSelSectSPDR®ETF | |||
| KAMO | 24.75 | 0.02 | +0.10% |
| Kensington Credit Opportunities ETF | |||
| BMED | 28.56 | N/A | N/A |
| iShares Health Innovation Active ETF | |||
| MBOX | 40.00 | -0.04 | -0.10% |
| Freedom Day Dividend ETF | |||
| BBSC | 88.60 | -0.31 | -0.35% |
| JPMorgan BetaBuilders US Sml Cp Eq ETF | |||